CLINICAL_TRIALS
trial_result
· 2017-01-31
Clinical Trial Update: A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma [Phase 2]
Summary
A Phase 2 trial evaluating sunitinib in patients with unresectable or advanced cholangiocarcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Unresectable and Advanced Cholangiocarcinoma | Phase 2 | Status: COMPLETED